## FTV: Fortive Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.29 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($51.77)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Loomis Sayles & Co. L P Purchases New Shares in Fortive Corporation $FTV**
- Source: MarketBeat | 20251203T122217 | Neutral | Relevance: 100%
- Loomis Sayles & Co. L P acquired a new position of 144,081 shares in Fortive Corporation, valued at approximately $7.51 million, during the second quarter. Other institutional investors like Norges Bank, Quadrature Capital Ltd, Level Four Advisory Services LLC, HSBC Holdings PLC, and Bank of Nova Scotia Trust Co. also made significant changes to their holdings, with institutional investors now owning 94.94% of Fortive's stock. The article also details Fortive's stock performance, dividend announcement, and recent analyst ratings, which currently average a "Hold" with a target price of $57.38.

**2. Distillate Capital Partners LLC Makes New $9.92 Million Investment in Fortive Corporation $FTV**
- Source: MarketBeat | 20251203T095511 | Somewhat-Bullish | Relevance: 100%
- Distillate Capital Partners LLC has made a new $9.92 million investment in Fortive Corporation, acquiring 190,206 shares in the second quarter. This move highlights significant institutional interest, as Fortive also reported Q2 EPS of $0.80 on $1.07 billion in revenue and declared a quarterly dividend. The company maintains a "Hold" rating from Wall Street with a consensus price target of $57.38.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-05 | Morgan Stanley | $53 | $50 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-05 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($3.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Dodge & Cox Inc.: 13.4% (+28.4%)
- Vanguard Group Inc: 12.3% (-0.8%)
- Blackrock Inc.: 9.8% (-0.5%)
- Viking Global Invest: 6.5% (+28.7%)
- Price (T.Rowe) Assoc: 4.9% (+8.3%)

### Key Risks

1. Insider selling cluster: $3.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.29 suggests fair value with growth premium. Forward P/E 18.9x stretched relative to 8% growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($3.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.8B |
| Beta | 1.04 |
| 52W Range | $45.50 - $62.79 |
| Short Interest | 5.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.29 |
| Forward P/E | 18.9 |
| Current P/E | 20.3 |
| YoY Growth | 7.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 3.3pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 3.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.72% (CS: 60) | Neutral |
| RSI_14 | 66.2 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.062x | Above |
| vs SMA200 | 1.040x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $53.75
- **Stop Loss:** $51.77 (3.7% risk)
- **Target:** $57.71 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 505
- **Position Value:** $27,143.75
- **Portfolio %:** 27.14%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-04 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.57 | $0.68 | +19.5% |
| 2025Q2 | $0.59 | $0.58 | -2.1% |
| 2025Q1 | $0.85 | $0.85 | -0.2% |
| 2024Q4 | $1.12 | $1.17 | +4.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*